JPRN-UMIN000026040
Recruiting
N/A
Biomarker studies for potentially predicting response to nivolumab in patients with unresectable or recurrent non-small cell lung cancer - Biomarker studies for nivolumab
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- unresectable or recurrent non-small cell lung cancer
- Sponsor
- Kagoshima University
- Enrollment
- 90
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\)Subjects with autoimmune disease. (2\)Subjects with interstitial lung disease. (3\)Receiving continuous systemic corticosteroid. (4\)Prior therapy with antibody or drug specifically targeting T\-cell co\-stimulation or checkpoint pathways. (5\)Patients with a history of hypersensitivity to nivolumab. (6\)Dementia or psychological disorder difficult to participate in this clinical study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Exploratory study of biomarkers predicting response to nivolumab in non-small-cell lung canceron-small-cell lung cancerJPRN-UMIN000022505Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine200
Completed
N/A
Research for biomarkers to predict the effectiveness of zoledronic acid in metastatic bone tumorsPatients with bone metastases newly treated by zoledronic acidJPRN-UMIN000018556agoya University Graduate School and School of Medicine27
Completed
N/A
Research for biomarkers to predict the effectiveness of denosumab in metastatic bone tumorsPatients with bone metastases newly treated by denosumabJPRN-UMIN000019700agoya University Graduate School and School of Medicine40
Completed
N/A
Identification of biomarkers that predict responsiveness to Dupilumab among severe asthmaJPRN-UMIN000041915ational Hospital Organization Tokyo National Hospital15
Active, Not Recruiting
Phase 1
prediction of response to therapy in inflammatory bowel diseaseEUCTR2018-002925-47-ESFundación de Investigación Biomédica del Hospital Universitario de La Princesa180